KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Opko Health (OPK) Shares Issued (2016 - 2023)

Opko Health filings provide 14 years of Shares Issued readings, the most recent being -$545000.0 for Q4 2023.

On a quarterly basis, Shares Issued rose 62.72% to -$545000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was -$1.3 million, a 64.21% decrease, with the full-year FY2023 number at -$272000.0, up 64.86% from a year prior.
Shares Issued hit -$545000.0 in Q4 2023 for Opko Health, down from $273000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $76.1 million in Q4 2019 to a low of -$1.5 million in Q4 2022.
Median Shares Issued over the past 5 years was $168500.0 (2021), compared with a mean of $5.5 million.
Biggest five-year swings in Shares Issued: soared 131.03% in 2021 and later tumbled 827.36% in 2022.
Opko Health's Shares Issued stood at $76.1 million in 2019, then tumbled by 99.89% to $87000.0 in 2020, then soared by 131.03% to $201000.0 in 2021, then tumbled by 827.36% to -$1.5 million in 2022, then surged by 62.72% to -$545000.0 in 2023.
The last three reported values for Shares Issued were -$545000.0 (Q4 2023), $273000.0 (Q3 2023), and -$1.5 million (Q4 2022) per Business Quant data.